1 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00244
D00244
|
Betamethasone
| [1] 235 235 |
2 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00292
D00292
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
3 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00972
D00972
|
Betamethasone
| [1] 235 235 |
4 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00975
D00975
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
5 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01357
D01357
|
Betamethasone
| [1] 235 235 |
6 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01402
D01402
|
Betamethasone
| [1] 235 235 |
7 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01510
D01510
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
8 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01615
D01615
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
9 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01632
D01632
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
10 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01637
D01637
|
Betamethasone
| [1] 235 235 |
11 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D01948
D01948
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
12 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D02032
D02032
|
Betamethasone
| [1] 235 235 |
13 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D02174
D02174
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
14 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D02286
D02286
|
Betamethasone
| [1] 235 235 |
15 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D02591
D02591
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
16 |
NR3C1
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D02592
D02592
|
Dexamethasone
| [5] 235 235, 257, 283, 296, 299 |
17 |
PTH1R
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption | D05364
D05364
|
Parathyroid hormone
| [4] 65 65, 70, 235, 326 |
18 |
PTH1R
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption | D06078
D06078
|
Teriparatide
| [7] 46 46, 65, 68, 70, 71, 235, 274 |
19 |
PTH2R
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D05364
D05364
|
Parathyroid hormone
| [2] 235 235, 326 |
20 |
SLC12A3
| - | D00340
D00340
|
Hydrochlorothiazide
| [1] 235 235 |
21 |
VDR
| [5] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation | D00129
D00129
|
Calcitriol
| [9] 18 18, 37, 46, 49, 66, 96, 158, 235, 326 |
22 |
VDR
| [5] Parathyroid hormone synthesis, secretion and action Parathyroid hormone synthesis, secretion and action, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis, Chemical carcinogenesis - receptor activation | D01518
D01518
|
Alfacalcidol
| [8] 41 41, 46, 49, 50, 96, 107, 235, 238 |